Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROACTIV: Telbivudine Combinations in Chronic Hepatitis B
NCT00409019Phase 4Withdrawn
- Sponsor
- Novartis
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Novartis. Status: withdrawn.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00409019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409019.